Clinical Trial Update: Longitudinal Study of Brain Amyloid imaGing in MEMENTO [Phase 3]

View source ↗

Summary

Phase 3 longitudinal study update on brain amyloid imaging in Alzheimer's disease and related disorders (NCT02164643) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Alzheimer's Disease (AD) and Related Disorders | Phase 3 | Status: COMPLETED